These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

239 related items for PubMed ID: 15027122

  • 1. D-PCa-2: a novel transcript highly overexpressed in human prostate and prostate cancer.
    Weigle B, Kiessling A, Ebner R, Fuessel S, Temme A, Meye A, Schmitz M, Rieger MA, Ockert D, Wirth MP, Rieber EP.
    Int J Cancer; 2004 May 10; 109(6):882-92. PubMed ID: 15027122
    [Abstract] [Full Text] [Related]

  • 2. D-TMPP: a novel androgen-regulated gene preferentially expressed in prostate and prostate cancer that is the first characterized member of an eukaryotic gene family.
    Kiessling A, Weigle B, Fuessel S, Ebner R, Meye A, Rieger MA, Schmitz M, Temme A, Bachmann M, Wirth MP, Rieber EP.
    Prostate; 2005 Sep 01; 64(4):387-400. PubMed ID: 15761874
    [Abstract] [Full Text] [Related]

  • 3. PSGR2, a novel G-protein coupled receptor, is overexpressed in human prostate cancer.
    Weng J, Wang J, Hu X, Wang F, Ittmann M, Liu M.
    Int J Cancer; 2006 Mar 15; 118(6):1471-80. PubMed ID: 16206286
    [Abstract] [Full Text] [Related]

  • 4. Multiple tumor marker analyses (PSA, hK2, PSCA, trp-p8) in primary prostate cancers using quantitative RT-PCR.
    Fuessel S, Sickert D, Meye A, Klenk U, Schmidt U, Schmitz M, Rost AK, Weigle B, Kiessling A, Wirth MP.
    Int J Oncol; 2003 Jul 15; 23(1):221-8. PubMed ID: 12792797
    [Abstract] [Full Text] [Related]

  • 5. D-GPCR: a novel putative G protein-coupled receptor overexpressed in prostate cancer and prostate.
    Weigle B, Fuessel S, Ebner R, Temme A, Schmitz M, Schwind S, Kiessling A, Rieger MA, Meye A, Bachmann M, Wirth MP, Rieber EP.
    Biochem Biophys Res Commun; 2004 Sep 10; 322(1):239-49. PubMed ID: 15313197
    [Abstract] [Full Text] [Related]

  • 6. Expression and regulation of prostate androgen regulated transcript-1 (PART-1) and identification of differential expression in prostatic cancer.
    Sidiropoulos M, Chang A, Jung K, Diamandis EP.
    Br J Cancer; 2001 Aug 03; 85(3):393-7. PubMed ID: 11487271
    [Abstract] [Full Text] [Related]

  • 7. High expression of a new marker PCA-1 in human prostate carcinoma.
    Konishi N, Nakamura M, Ishida E, Shimada K, Mitsui E, Yoshikawa R, Yamamoto H, Tsujikawa K.
    Clin Cancer Res; 2005 Jul 15; 11(14):5090-7. PubMed ID: 16033822
    [Abstract] [Full Text] [Related]

  • 8. A novel human prostate-specific gene-1 (HPG-1): molecular cloning, sequencing, and its potential involvement in prostate carcinogenesis.
    Herness EA, Naz RK.
    Cancer Res; 2003 Jan 15; 63(2):329-36. PubMed ID: 12543784
    [Abstract] [Full Text] [Related]

  • 9. Reverse transcriptase polymerase chain reaction for prostate specific antigen in the management of prostate cancer.
    Gomella LG, Raj GV, Moreno JG.
    J Urol; 1997 Aug 15; 158(2):326-37. PubMed ID: 9224297
    [Abstract] [Full Text] [Related]

  • 10. Transcript quantification of Dresden G protein-coupled receptor (D-GPCR) in primary prostate cancer tissue pairs.
    Fuessel S, Weigle B, Schmidt U, Baretton G, Koch R, Bachmann M, Rieber EP, Wirth MP, Meye A.
    Cancer Lett; 2006 May 08; 236(1):95-104. PubMed ID: 15979782
    [Abstract] [Full Text] [Related]

  • 11. Prostate-specific antigen mRNA and protein levels in laser microdissected cells of human prostate measured by real-time reverse transcriptase-quantitative polymerase chain reaction and immuno-quantitative polymerase chain reaction.
    Pinzani P, Lind K, Malentacchi F, Nesi G, Salvianti F, Villari D, Kubista M, Pazzagli M, Orlando C.
    Hum Pathol; 2008 Oct 08; 39(10):1474-82. PubMed ID: 18619642
    [Abstract] [Full Text] [Related]

  • 12. Expression patterns of candidate susceptibility genes HNF1β and CtBP2 in prostate cancer: association with tumor progression.
    Debiais-Delpech C, Godet J, Pedretti N, Bernard FX, Irani J, Cathelineau X, Cussenot O, Fromont G.
    Urol Oncol; 2014 May 08; 32(4):426-32. PubMed ID: 24332637
    [Abstract] [Full Text] [Related]

  • 13. Bax inhibitor-1 is overexpressed in prostate cancer and its specific down-regulation by RNA interference leads to cell death in human prostate carcinoma cells.
    Grzmil M, Thelen P, Hemmerlein B, Schweyer S, Voigt S, Mury D, Burfeind P.
    Am J Pathol; 2003 Aug 08; 163(2):543-52. PubMed ID: 12875974
    [Abstract] [Full Text] [Related]

  • 14. Isolation and characterization of the major form of human MUC18 cDNA gene and correlation of MUC18 over-expression in prostate cancer cell lines and tissues with malignant progression.
    Wu GJ, Wu MW, Wang SW, Liu Z, Qu P, Peng Q, Yang H, Varma VA, Sun QC, Petros JA, Lim SD, Amin MB.
    Gene; 2001 Nov 14; 279(1):17-31. PubMed ID: 11722842
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. The search for secreted proteins in prostate cancer by the Escherichia coli ampicillin secretion trap: expression of NBL1 is highly restricted to the prostate and is related to cancer progression.
    Hayashi T, Sentani K, Oue N, Ohara S, Teishima J, Anami K, Sakamoto N, Matsubara A, Yasui W.
    Pathobiology; 2013 Nov 14; 80(2):60-9. PubMed ID: 22948749
    [Abstract] [Full Text] [Related]

  • 20. Profiling protein markers associated with lymph node metastasis in prostate cancer by DIGE-based proteomics analysis.
    Pang J, Liu WP, Liu XP, Li LY, Fang YQ, Sun QP, Liu SJ, Li MT, Su ZL, Gao X.
    J Proteome Res; 2010 Jan 14; 9(1):216-26. PubMed ID: 19894759
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.